HUMABIO - Human Monitoring and Authentication using Biodynamic Indicators and Behavioural Analysis
OVERVIEW
HUMABIO-EU.ORG TRAFFIC
Date Range
Date Range
Date Range
HUMABIO-EU.ORG HISTORY
WEB PAGE SPAN
LINKS TO HUMABIO-EU.ORG
You are viewing the non-styled version of our site. ACTIBIO - Unobtrusive Authentication Using ACTIvity Related and Soft BIOmetrics. ACTIBIO project video is now available for download. Please download it from here. Feature article for Actibio project in Cordis. Posted on Mon, Apr 1.
WHAT DOES HUMABIO-EU.ORG LOOK LIKE?



CONTACTS
Fraunhofer Institut IAO
- -
Nobelstr.12
Stuttgart, --, 70569
DE
HUMABIO-EU.ORG SERVER
NAME SERVERS
SERVER SOFTWARE AND ENCODING
We revealed that this website is operating the Apache operating system.SITE TITLE
HUMABIO - Human Monitoring and Authentication using Biodynamic Indicators and Behavioural AnalysisDESCRIPTION
HUMABIO - Human Monitoring and Authentication using Biodynamic Indicators and Behavioural AnalysisPARSED CONTENT
The web site humabio-eu.org states the following, "HUMABIO - Human Monitoring and Authentication using Biodynamic Indicators and Behavioural Analysis." I noticed that the webpage stated " HUMABIO is a EC co-funded Specific Targeted Research Project STREP where new types of biometrics are combined with state of the art sensorial technologies in order to enhance security in a wide spectrum of applications like transportation safety and continuous authentication in safety critical environments like laboratories, airports or other buildings." They also said " Research will be focused on the following issues." The meta header had HUMABIO - Human Monitoring and Authentication using Biodynamic Indicators and Behavioural Analysis as the first optimized keyword.SEE SIMILAR DOMAINS
Subscribe to our mailing list.
ARNOLD CLASSIC SOUTH AFRICA CHAMPION 2016. Your browser does not support HTML5 video.
Humabs is using its cutting-edge proprietary CellClone technologies to discover effective new treatments against a variety of viral and bacterial infections. Humabs has also a portfolio of programs to address major public health threats, such as Ebola, Zika, Rabies and Dengue. Humabs BioMed is now a subsidiary of Vir Biotechnology.